Company expands presence and support in US market. Proprietary TOCE™ technology overcomes PCR testing limitations for high multiplex applications.
Press Release
–
Jan 5, 2023 17:00 PST
IRVINE, Calif., January 5, 2023 (Newswire.com)
–
Seegene Technologies, Inc., a subsidiary of Seegene Inc., South Korea’s leading molecular diagnostics company, announced it will change names and begin doing business as Seegene USA, Inc., effective Jan. 1, 2023. The new name reflects an expanding presence in the US for the organization and aligns with a commitment to increase support of the U.S. customer base. All Seegene services and products, including the Novaplex™ assay reagents1 for infectious disease…
